3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Lymphoma, Follicular
7
Lymphoma, B-Cell, Marginal Zone
7
Breast Neoplasms
7
Lymphoma, Non-Hodgkin
6
Lymphoma, Mantle-Cell
6
Lymphoma, Large B-Cell, Diffuse
5
Leukemia, Myeloid, Acute
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Leukemia
5
Congenital Abnormalities
5
Carcinoma, Ovarian Epithelial
5
Waldenstrom Macroglobulinemia
4
Lymphoma, Large-Cell, Immunoblastic
4
Burkitt Lymphoma
4
Myelodysplastic Syndromes
3
Melanoma
3
Lung Neoplasms
3
Leukemia, Myeloid, Chronic-Phase
3
Leukemia, Myeloid, Accelerated Phase
3
Carcinoma, Non-Small-Cell Lung
3
Blast Crisis
3
Wilms Tumor
2
Uterine Cervical Neoplasms
2
Uterine Cervical Dysplasia
2
Testicular Neoplasms
2
Stomach Neoplasms
2
Sezary Syndrome
2
Recurrence
2
Prostatic Neoplasms
2
Interventions
Biopsy
3
Microarray Analysis
2
Methylprednisolone
2
Filgrastim
2
Cyclophosphamide
2
Colposcopy
2
Carboplatin
2
sargramostim
1
pyroxamide
1
pirfenidone
1
human papillomavirus vaccine, TA
1
artemisinin
1
arginine butyrate
1
Zoledronic Acid
1
Video-Assisted Surgery
1
Topotecan
1
Tetradecanoylphorbol Acetate
1
Tacrolimus
1
Sodium Chloride
1
Radiotherapy
1
Prednisone
1
Polymerase Chain Reaction
1
Peripheral Blood Stem Cell Transplantation
1
Light Coagulation
1
Leucovorin
1
Interleukin-12 Subunit p35
1
Interferon-alpha
1
Inositol
1
Immunoenzyme Techniques
1
Imiquimod
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Precancerous Conditions
×
Flow Cytometry
×
Clear all
NCT00629577
2017-02-01
SAGE
British Columbia Cancer Agency
Phase 1
Terminated
50 enrolled